Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NHS England
Pharma
NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai
After reviewing additional clinical data, England's NICE has slapped down Eli Lilly's Kisunla and Biogen and Eisai's Leqembi for a second time.
Kevin Dunleavy
Mar 6, 2025 10:47am
Vertex inks long-term access deal for CF meds in England
Jun 21, 2024 11:31am
Kate Middleton's cancer reveal sends NHS searches skyrocketing
Mar 27, 2024 12:04pm
Pharma industry reaches 'landmark' drug spending deal with UK
Nov 20, 2023 11:00am
Novartis scraps key UK Leqvio study
Mar 22, 2023 11:55am
AbbVie, Lilly exit UK pricing accord over 'punitive' clawbacks
Jan 17, 2023 10:45am
